Author:
Yamamoto Kazuhito,Emi Nobuhiko,Kajiguchi Tomohiro,Yamamori Shunji,Ono Yoshitaka,Naoe Tomoki
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Melnick A, Licht JD. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood. 1999;93:3167-3215.
2. Chen GQ, Shi XG, Tang W, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL), I: As2O3 exerts dose-dependent dual effects on APL cells. Blood. 1997;89: 3345-3353.
3. Kitamura K, Minami Y, Yamamoto K, et al. Involvement of CD95- independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia. 2000;14:1743-1750.
4. Camacho LH, Soignet SL, Chanel S, et al. Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. J Clin Oncol. 2000;18: 2620-2625.
5. Ghosh K, Varma N, Dash S. Dysplastic eosinophils in three patients with acute promyelocytic leukaemia. Leuk Res. 1988;12:963-967.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献